- Home
- DOYU vs CATX Comparison
DOYU vs CATX Comparison
Compare DOYU & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOYU | CATX |
|---|---|---|
| Founded | 2014 | 1983 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.4M | 97.7M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DOYU | CATX |
|---|---|---|
| Price | $3.89 | $0.84 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 16 |
| Target Price | $4.80 | ★ $9.93 |
| AVG Volume (30 Days) | 25.5K | ★ 3.7M |
| Earning Date | 11-23-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $46.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.42 | $0.78 |
| 52 Week High | $7.23 | $6.16 |
Technical Indicators
Market Signals| Indicator | DOYU | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 54.01 | 23.09 |
| Support Level | $3.42 | N/A |
| Resistance Level | $4.87 | $2.40 |
| Average True Range (ATR) | 0.17 | 0.21 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 87.72 | 4.07 |
Price Performance
Historical ComparisonAbout DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company aims to build an integrated game-centric ecosystem of livestreaming, video, voice, graphic content, and other interactive and community features. The company operates the platform both on mobile apps and PC portals, through which users can enjoy immersive and interactive games and entertainment livestreaming, access a wide array of video and graphic content, and participate in community events and discussions.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.